Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Small Molecule POC Biosensor Technology to Revolutionize Early Disease Detection

By LabMedica International staff writers
Posted on 11 Mar 2024

Aptamers, biosensors made from nucleic acids that bind to specific proteins or small molecules, are increasingly employed in diagnosing various diseases. More...

Their application in cancer detection is particularly promising due to the high cure rate possible with early cancer detection. However, aptamers face significant challenges, such as susceptibility to degradation or aggregation by nucleases and charged proteins found in biological samples like blood or saliva. This limitation has hampered their direct use in clinical samples without prior removal of these molecules. Now, a research team has addressed this issue by using a protein-based microcapsule.

Researchers from Pohang University of Science and Technology (POSTECH, Gyeongbuk, Korea) have devised an aptamer sensor system capable of rapid detection of target molecules directly from biological samples, thus eliminating the need for pretreatment processes. They have developed spherical microcapsules called proteinosomes, based on the self-assembly of protein-polymer amphiphiles. These microcapsules encase an aptasensor featuring a structure-switching aptamer that reacts with target molecules to emit a fluorescent signal instantly. The exterior of the microcapsule consists of a size-selective, semi-permeable membrane, designed to allow only small target molecules through while blocking larger, damaging proteins.

This innovative system maintains the aptasensor's optimal performance in untreated biofluids, thus enabling the efficient and quick detection of targets like estradiol, linked to reproductive organ cancers; dopamine, associated with Parkinson’s and Alzheimer’s diseases; and cocaine, which necessitates rapid detection. The capsules safeguard the aptasensors effectively against harmful proteins. For instance, aptasensors within these microcapsules remained unharmed for 18 hours in high concentration nuclease solutions, much more concentrated than typical serum levels. Moreover, by exploiting each capsule's capability to function as a distinct 'reaction vessel,' the team demonstrated the independent operation of multiple aptasensors in a single mixture. This allows for the simultaneous, real-time sensing of various target molecules and monitoring their concentration changes.

"By integrating sample separation and target detection, we have pioneered a novel small molecule point-of-care biosensor technology that is directly applicable to biological samples such as serum," said Professor Seung Soo Oh who led the research. "This platform has the potential to revolutionize medicine, spanning early disease detection and personalized treatment."

Related Links:
POSTECH


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.